Ye zai sheng
Ye zai sheng
Fuzhou, Fujian, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell Carcinoma | Immunotherapy Esophagus Cancer | Recruiting | Phase 2 | 2024-02-07 | NCT05515315 |